NCT05035043Completed
Economic Burden of NAFLD
The Economic Burden of Non-Alcoholic Fatty Liver Disease Patients in Flanders, Belgium
Source: ClinicalTrials.gov · Last updated 1 Dec 2025
Brief summary (registry, in English)
To determine the economic burden of NAFLD (Non-Alcoholic-Fatty-Liver Disease) patients in Belgium, Flanders by means of a bottom-up approach.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 73 (actual)
- First submitted
- 30 Aug 2021
- Start date
- 1 Mar 2021
- Primary completion date
- 30 Apr 2024
- Lead sponsor
- Hasselt University
- Diseases
- Fatty liver disease (MASLD/MASH)
- NCT number
- NCT05035043
What you commit to
- Study type: Interventional
- Participants enrolled: 73
- From 1 Mar 2021 to the primary completion date, 30 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- \>70 years
Other
- unable to give informed consent
Who the study is looking for
- having NAFLD as was diagnosed by FibroScan®,
- 18 years or older
- BMI ≥ 25 kg/m²
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hasselt University Coordinator of this site? Confirm its status | Hasselt | Belgium | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.